European Companies Concerned About Regulatory Environment in China - European Chamber Of Commerce Survey
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The rule of law and transparent policy-making and implementation will be the most important factors in China's economic performance in the years ahead, a survey of European companies shows
You may also be interested in...
EU Chamber Of Commerce Urges Bold Reforms On Market Access By China’s New Leaders
The European Chamber of Commerce in China calls on Beijing to break the grip of state-owned companies on market access and seize a “historic opportunity” of a leadership transition to open the economy.
Are China's Rising Labor Costs Good For Big Pharma?
HONG KONG - Rising labor costs are putting stress on manufacturing operations in China, but may prove to be a boon in the long term for companies focused on the world's fastest-growing domestic market
China To De-link Indigenous Innovation And Public Procurement Policies - U.S.-China Strategic And Economic Dialogue
WASHINGTON - In a positive move for the life sciences industry and others conducting business in China, Chinese leaders have agreed to de-link indigenous innovation policies from government procurement, a decision that - if fully implemented - would provide a fairer competitive environment for foreign-invested enterprises in China